Works matching IS 14783223 AND DT 2021 AND VI 41 AND IP 2

Results: 24

Frailty in outpatients with cirrhosis: A prospective observational study.

Published in:

Liver International, 2021, v. 41, n. 2, p. 357, doi. 10.1111/liv.14694

By:

Román, Eva;
Parramón, Marc;
Flavià, Montserrat;
Gely, Cristina;
Poca, Maria;
Gallego, Adolfo;
Santesmases, Rosalia;
Hernández, Elvira;
Nieto, Juan C.;
Urgell, Eulàlia;
Alvarado‐Tapias, Edilmar;
Vidal, Silvia;
Ferrero‐Gregori, Andreu;
Vargas, Víctor;
Guarner, Carlos;
Soriano, German

Publication type:

Article

The tireless search to improve the prognostic assessment of intrahepatic cholangiocarcinoma: An urgent need.

Published in:

Liver International, 2021, v. 41, n. 2, p. 252, doi. 10.1111/liv.14768

By:

Muñoz‐Martínez, Sergio;
Forner, Alejandro

Publication type:

Article

Issue Cover.

Published in:

Liver International, 2021, v. 41, n. 2, p. i, doi. 10.1111/liv.14787

By:

Giersch, Katja;
Hermanussen, Lennart;
Volz, Tassilo;
Kah, Janine;
Allweiss, Lena;
Casey, John;
Sureau, Camille;
Dandri, Maura;
Lütgehetmann, Marc

Publication type:

Article

Screening varices in patients with HBV‐related cirrhosis on antiviral therapy: Platelet alone or together with LSM.

Published in:

Liver International, 2021, v. 41, n. 2, p. 369, doi. 10.1111/liv.14752

By:

Wang, Bingqiong;
Zhou, Jialing;
Wu, Xiaoning;
Sun, Yameng;
Li, Lei;
Li, Ping;
Li, Minghui;
Jiang, Wei;
Xu, Mingyi;
Feng, Bo;
Xu, Xiaoyuan;
Cheng, Jilin;
Xie, Wen;
Han, Tao;
Wang, Xiaozhong;
Li, Hai;
Piao, Hongxin;
Wu, Shanshan;
Shi, Yiwen;
Chen, Shuyan

Publication type:

Article

Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case‐control study.

Published in:

Liver International, 2021, v. 41, n. 2, p. 271, doi. 10.1111/liv.14745

By:

Fiore, Vito;
Ranieri, Roberto;
Dell'Isola, Serena;
Pontali, Emanuele;
Barbarini, Giorgio;
Prestileo, Tullio;
Marri, Daniele;
Starnini, Giulio;
Sotgiu, Giovanni;
Madeddu, Giordano;
Babudieri, Sergio

Publication type:

Article

Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: Results from the HIDIT‐II study.

Published in:

Liver International, 2021, v. 41, n. 2, p. 295, doi. 10.1111/liv.14740

By:

Bremer, Birgit;
Anastasiou, Olympia E.;
Hardtke, Svenja;
Caruntu, Florin Alexandru;
Curescu, Manuela G.;
Yalcin, Kendal;
Akarca, Ulus S.;
Gürel, Selim;
Zeuzem, Stefan;
Erhardt, Andreas;
Lüth, Stefan;
Papatheodoridis, George V.;
Radu, Monica;
Idilman, Ramazan;
Manns, Michael P.;
Cornberg, Markus;
Yurdaydin, Cihan;
Wedemeyer, Heiner

Publication type:

Article

The NAFLD‐MAFLD debate: Eminence vs evidence.

Published in:

Liver International, 2021, v. 41, n. 2, p. 255, doi. 10.1111/liv.14739

By:

Fouad, Yasser;
Elwakil, Reda;
Elsahhar, Medhat;
Said, Ebada;
Bazeed, Shamardan;
Ali Gomaa, Ahmed;
Hashim, Almoutaz;
Kamal, Enas;
Mehrez, Mai;
Attia, Dina

Publication type:

Article

Peri‐complication diagnosis of HCV among immigrants.

Published in:

Liver International, 2021, v. 41, n. 2, p. 421, doi. 10.1111/liv.14737

By:

Lapointe‐Shaw, Lauren;
Feld, Jordan J.

Publication type:

Article

Neutrophil extracellular traps enhance procoagulant activity and thrombotic tendency in patients with obstructive jaundice.

Published in:

Liver International, 2021, v. 41, n. 2, p. 333, doi. 10.1111/liv.14725

By:

Zhang, Jinming;
Yu, Muxin;
Liu, Biou;
Zhou, Peng;
Zuo, Nan;
Wang, Yufeng;
Feng, Yiming;
Zhang, Yue;
Wang, Jiaojiao;
He, Yujing;
Wu, Yinsong;
Dong, Zengxiang;
Hong, Luojia;
Shi, Jialan

Publication type:

Article

Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis.

Published in:

Liver International, 2021, v. 41, n. 2, p. 348, doi. 10.1111/liv.14726

By:

Janik, Maciej K.;
Kruk, Beata;
Szczepankiewicz, Benedykt;
Kostrzewa, Konrad;
Raszeja‐Wyszomirska, Joanna;
Górnicka, Barbara;
Lammert, Frank;
Milkiewicz, Piotr;
Krawczyk, Marcin

Publication type:

Article

The association of low‐grade albuminuria with incident nonalcoholic fatty liver disease and non‐invasive markers of liver fibrosis by glycemic status.

Published in:

Liver International, 2021, v. 41, n. 2, p. 422, doi. 10.1111/liv.14722

By:

Xin, Zhuojun;
Xu, Yu;
Li, Mian;
Zhao, Zhiyun

Publication type:

Article

PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD.

Published in:

Liver International, 2021, v. 41, n. 2, p. 321, doi. 10.1111/liv.14711

By:

Grimaudo, Stefania;
Bartesaghi, Stefano;
Rametta, Raffaela;
Marra, Fabio;
Margherita Mancina, Rosellina;
Pihlajamäki, Jussi;
Kakol‐Palm, Dorota;
Andréasson, Anne‐Christine;
Dongiovanni, Paola;
Ludovica Fracanzani, Anna;
Lori, Giulia;
Männistö, Ville;
Pellegrini, Giovanni;
Bohlooly‐Y, Mohammad;
Pennisi, Grazia;
Maria Pipitone, Rosaria;
Spagnuolo, Rocco;
Craxì, Antonio;
Lindén, Daniel;
Valenti, Luca

Publication type:

Article

Monofocal hepatocellular carcinoma: How much does size matter?

Published in:

Liver International, 2021, v. 41, n. 2, p. 396, doi. 10.1111/liv.14718

By:

Pelizzaro, Filippo;
Penzo, Barbara;
Peserico, Giulia;
Imondi, Angela;
Sartori, Anna;
Vitale, Alessandro;
Cillo, Umberto;
Giannini, Edoardo G.;
Forgione, Antonella;
Ludovico Rapaccini, Gian;
Di Marco, Maria;
Caturelli, Eugenio;
Zoli, Marco;
Sacco, Rodolfo;
Cabibbo, Giuseppe;
Marra, Fabio;
Mega, Andrea;
Morisco, Filomena;
Gasbarrini, Antonio;
Svegliati‐Baroni, Gianluca

Publication type:

Article

Extrahepatic portosystemic shunt with hyperammonaemia.

Published in:

Liver International, 2021, v. 41, n. 2, p. 408, doi. 10.1111/liv.14710

By:

Luangsukrerk, Thanawat;
Tiankanon, Kasenee;
Mekaroonkomol, Parit;
Rerknimitr, Rungsun

Publication type:

Article

Delayed diagnosis and disparity in hepatitis C virus‐infected immigrants in North America: A call for action.

Published in:

Liver International, 2021, v. 41, n. 2, p. 420, doi. 10.1111/liv.14709

By:

Emhmed Ali, Saad;
Nguyen, Mindie H.

Publication type:

Article

Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B.

Published in:

Liver International, 2021, v. 41, n. 2, p. 288, doi. 10.1111/liv.14701

By:

Lee, Soon Kyu;
Kwon, Jung Hyun;
Lee, Sung Won;
Jang, Jeong Won;
Nam, Heechul;
Baik, Kyoung Won;
Yoo, Sun Hong;
Nam, Soon Woo;
Sung, Pil Soo;
Bae, Si Hyun;
Choi, Jong Young;
Yoon, Seung Kew

Publication type:

Article

Murine hepatocytes do not support persistence of Hepatitis D virus mono‐infection in vivo.

Published in:

Liver International, 2021, v. 41, n. 2, p. 410, doi. 10.1111/liv.14677

By:

Giersch, Katja;
Hermanussen, Lennart;
Volz, Tassilo;
Kah, Janine;
Allweiss, Lena;
Casey, John;
Sureau, Camille;
Dandri, Maura;
Lütgehetmann, Marc

Publication type:

Article

Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C successfully treated with direct‐acting antiviral agents.

Published in:

Liver International, 2021, v. 41, n. 2, p. 276, doi. 10.1111/liv.14676

By:

Ciancio, Alessia;
Ribaldone, Davide G.;
Dotta, Anna;
Giordanino, Chiara;
Sacco, Marco;
Fagoonee, Sharmila;
Pellicano, Rinaldo;
Saracco, Giorgio M.

Publication type:

Article

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review.

Published in:

Liver International, 2021, v. 41, n. 2, p. 261, doi. 10.1111/liv.14669

By:

Lee, Jenny;
Vali, Yasaman;
Boursier, Jerome;
Spijker, Rene;
Anstee, Quentin M.;
Bossuyt, Patrick M.;
Zafarmand, Mohammad H.

Publication type:

Article

Association between consumption of edible seaweeds and newly diagnosed non‐alcohol fatty liver disease: The TCLSIH Cohort Study.

Published in:

Liver International, 2021, v. 41, n. 2, p. 311, doi. 10.1111/liv.14655

By:

Li, Huiping;
Gu, Yeqing;
Wu, Xiaohui;
Rayamajhi, Sabina;
Bian, Shanshan;
Zhang, Qing;
Meng, Ge;
Liu, Li;
Wu, Hongmei;
Zhang, Shunming;
Wang, Yawen;
Zhang, Tingjing;
Wang, Xuena;
Thapa, Amrish;
Sun, Shaomei;
Wang, Xing;
Jia, Qiyu;
Song, Kun;
Niu, Kaijun

Publication type:

Article

The association of sex steroid hormone concentrations with non‐alcoholic fatty liver disease and liver enzymes in US men.

Published in:

Liver International, 2021, v. 41, n. 2, p. 300, doi. 10.1111/liv.14652

By:

Phan, Hong;
Richard, Aline;
Lazo, Mariana;
Nelson, William G.;
Denmeade, Samuel R.;
Groopman, John;
Kanarek, Norma;
Platz, Elizabeth A.;
Rohrmann, Sabine

Publication type:

Article

The prognostic role of soluble transforming growth factor‐β and its correlation with soluble programmed death‐ligand 1 in biliary tract cancer.

Published in:

Liver International, 2021, v. 41, n. 2, p. 388, doi. 10.1111/liv.14636

By:

Kim, Jin Won;
Lee, Kyung‐Hun;
Kim, Ji‐Won;
Suh, Koung Jin;
Nam, Ah‐Rong;
Bang, Ju‐Hee;
Jin, Mei Hua;
Oh, Kyoung‐Seok;
Kim, Jae‐Min;
Kim, Tae‐Yong;
Oh, Do‐Youn

Publication type:

Article

Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study.

Published in:

Liver International, 2021, v. 41, n. 2, p. 378, doi. 10.1111/liv.14567

By:

Lu, Liang‐He;
Zhong, Chong;
Wei, Wei;
Li, Shao‐Hua;
Mei, Jie;
Zou, Jing‐wen;
Guo, Rong‐Ping;
Zhang, Yong‐Fa

Publication type:

Article

Issue Information.

Published in:: Liver International, 2021, v. 41, n. 2, p. 247, doi. 10.1111/liv.14521
Publication type:: Article